دورية أكاديمية

A double blind, randomised, dose finding, phase II, multicentre study of radium-223 for the treatment of patients with metastatic castration-refractory prostate cancer (CRPC): EudraCT number: 2005-003680-22

التفاصيل البيبلوغرافية
العنوان: A double blind, randomised, dose finding, phase II, multicentre study of radium-223 for the treatment of patients with metastatic castration-refractory prostate cancer (CRPC): EudraCT number: 2005-003680-22
المؤلفون: Parker, C., Hoskin, R., Pascoe, S., Chodack, A., O'Sullivan, Joe, Germa, J.R., Lokna, A.
المصدر: Parker , C , Hoskin , R , Pascoe , S , Chodack , A , O'Sullivan , J , Germa , J R & Lokna , A 2009 , ' A double blind, randomised, dose finding, phase II, multicentre study of radium-223 for the treatment of patients with metastatic castration-refractory prostate cancer (CRPC): EudraCT number: 2005-003680-22 ' , EJC SUPPLEMENTS , vol. 7 , pp. 406-406 .
سنة النشر: 2009
المجموعة: Queen's University Belfast: Research Portal
مصطلحات موضوعية: /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, SDG 3 - Good Health and Well-being
نوع الوثيقة: article in journal/newspaper
اللغة: English
الإتاحة: https://pure.qub.ac.uk/en/publications/5084578e-67c8-41c6-a679-253433d9cfbcTest
حقوق: info:eu-repo/semantics/restrictedAccess
رقم الانضمام: edsbas.97AB188A
قاعدة البيانات: BASE